Press Releases and Statements
Your search for Press Release returned 1000 results.
APRIL 09, 2015
New Chief Human Resources OfficerJoins Bill & Melinda Gates Foundation
SEATTLE (April 9, 2015) – The Bill & Melinda Gates Foundation today announced that Steven Rice will join as Chief Human Resources Officer. Rice joins the foundation from Juniper Networks, where he most recently served as Executive Vice President of Human Resources.
APRIL 06, 2015
Emilio Emini Director of HIV
SEATTLE (April 6, 2015) — The Bill & Melinda Gates Foundation today announced that Emilio Emini, Ph.D, has been named director of HIV for the Global Health program. He will assume his new position on July 6, 2015.
MARCH 18, 2015
New Chief Digital Officer Joins Bill & Melinda Gates Foundation
SEATTLE, WA, USA (March 19, 2015) – The Bill & Melinda Gates Foundation today announced that Todd Pierce will join the organization in the newly created role of Chief Digital Officer. He comes to the foundation from salesforce.com where he served as Senior Vice President of the Healthcare and Life Sciences industry. Prior to salesforce.com, Pierce was Chief Information Officer at Genentech and for the County of Santa Clara, California, and held technology leadership roles at Roche and Veteran’s Affairs. Additionally, he has held key positions on multiple non-profit and foundation boards.
MARCH 05, 2015
The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology
SEATTLE, WA, USA and TÜBINGEN, GERMANY (March 5, 2015) – The Bill & Melinda Gates Foundation and CureVac today announced that the foundation has made a commitment to invest $52 million (€46 million) in CureVac, a leading clinical-stage biopharmaceutical company specializing in mRNA-based vaccine technologies. As part of the agreement, the foundation will also provide separate funding for several projects to develop prophylactic vaccines based on CureVac’s proprietary messenger RNA (mRNA) platform. In addition, CureVac’s longstanding investor dievini Hopp BioTech announced a commitment of $24 million (€21 million) of additional equity.